课题基金 / 基金详情

Pittsburgh Pediatric Rheumatology Training Grant

Pittsburgh Pediatric Rheumatology Training Grant
匹兹堡小儿风湿病培训补助金
批准号:
8655143
负责人:
JAY K KOLLS
金额:
$19.72万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-05-01 至 2015-06-30

项目摘要

项目成果

JAY K KOLLS的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): This is a renewal application for The Pittsburgh Pediatric Rheumatology Training Grant. Pediatric rheumatology focuses on musculoskeletal and autoimmune diseases of childhood. Serving this population of children are 237 board-certified pediatric rheumatologists in the United States (as of 2008). All but a handful of these are clinicians who do not engage in research. As a result, few pediatric rheumatologists have had research mentorship and they lack the skills to perform cutting edge research. The Division of Pediatric Rheumatology at the Children's Hospital of Pittsburgh, with substantial and sustained institutional support, has endeavored to create a national center of excellence offering comprehensive, state-of-the-art clinical care, educational programs, and competitive research involving clinical, translational, and basic sciences. Our Training Program is one of only two NIH-funded training programs dedicated to pediatric rheumatology. One of our central missions is to educate a new generation of academic pediatric rheumatologists who can play a leading role in the specialty as physician scientists. The goal is to provide a prime source of well- trained M.D. academic pediatric rheumatologists and Ph.D. scientists to serve the national need for cutting- edge research in the pediatric rheumatic diseases. To achieve this mission, we seek to provide, within a single center, the research role models, mentorship, and rich environment necessary for nurturing such individuals and ensuring their success. Support is requested to continue the current number of trainees in our program, currently four trainees per year, in order to provide two new trainees per year and two years of support for each trainee. The trainees will consist of two types of individuals. At least 75% will be pediatric rheumatology M.D. fellows who have completed a first year of clinical training. Following a first year of intensive clinical training, they will select a mentor from among the program faculty in order to gain exceptional research experience that will be used as the basis of an independent academic career. Up to 25% will be Ph.D. trainees who desire to focus their research careers in pediatric rheumatology. They will select a mentor from among the faculty who study the pediatric rheumatic diseases.
期刊论文(25)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/j.jpeds.2012.01.011
发表时间: 2012-07
期刊: JOURNAL OF PEDIATRICS
影响因子: 5.1
作者: [Gorelik, Mark, Wilson, David C., Cloonan, Yona K., Shulman, Stanford T., Hirsch, Raphael]
通讯作者: Hirsch, Raphael
A48: Durometer Measures Discriminate Affected versus Normal Skin in Pediatric Localized Scleroderma.
A48:硬度计测量可区分儿童局限性硬皮病中受影响的皮肤与正常皮肤。
DOI: --
发表时间: 2014
期刊: Arthritis & rheumatology (Hoboken, N.J.)
影响因子: --
作者: [Poff,Sarah, Li,SuzanneC, Kelsey,Christina, Foeldvari,Ivan, Torok,KathrynS]
通讯作者: Torok,KathrynS
Index of suspicion.
怀疑指数。
DOI: 10.1542/pir.34-11-531
发表时间: 2013
期刊: Pediatrics in review
影响因子: 1.3
作者: [Lee,Benjamin, Brown,AmandaG, Patel,AaratM, Torok,KathrynS, Muhammad,NinaAysha]
通讯作者: Muhammad,NinaAysha
A novel patient-reported outcome for paediatric localized scleroderma: a qualitative assessment of content validity.
儿童局限性硬皮病患者报告的新结果:内容有效性的定性评估。
DOI: 10.1111/bjd.18512
发表时间: 2020
期刊: The British journal of dermatology
影响因子: --
作者: [Zigler,CK, Ardalan,K, Lane,S, Schollaert,KL, Torok,KS]
通讯作者: Torok,KS
20
    Tulane StARR Program
    • 批准号:
      10608042
    • 项目类别:
    • 资助金额:
      $30.8万
    • 财政年份:
      2021
    • 负责人:
      JAY K KOLLS
    • 依托单位:
    Tulane StARR Program
    • 批准号:
      10318191
    • 项目类别:
    • 资助金额:
      $30.8万
    • 财政年份:
      2021
    • 负责人:
      JAY K KOLLS
    • 依托单位:
    Immunotherapy of KPC Infection
    • 批准号:
      9981924
    • 项目类别:
    • 资助金额:
      $48.64万
    • 财政年份:
      2020
    • 负责人:
      JAY K KOLLS
    • 依托单位:
    Immunotherapy of KPC Infection
    • 批准号:
      10443796
    • 项目类别:
    • 资助金额:
      $48.64万
    • 财政年份:
      2020
    • 负责人:
      JAY K KOLLS
    • 依托单位:
    海外基金